Notice of Q1 2016 Trading Update

21 January 2016

UDG Healthcare plc

Notice of Q1 2016 Trading Update

UDG Healthcare plc ("the Company"), a leading international healthcare services provider, will issue a trading update for the first quarter to December 31 2015 at 7.00 a.m. (GMT) on Tuesday, 2 February 2016.

The Company will also host a conference call for investors and analysts at 9.00am (GMT) on Tuesday, 2 February 2016 to discuss the statement. The dial-in details are as follows:

A playback facility will be available for seven days on +44 (0) 20 8196 1998. The access code for the replay will be 8829124.

For further information, please contact:

Keith Byrne

Head of Investor Relations

UDG Healthcare plc

Tel: +353-1-4632300

Lisa Kavanagh / Nick Dibden / Jack Hickey

Powerscourt

Tel: +44-207-250-1446

Email: [email protected]

About UDG Healthcare plc:

Listed on the London Stock Exchange, UDG Healthcare plc is a leading international provider of services to healthcare manufacturers and pharmacies, with operations in 20 countries including the US, UK, Ireland and Germany.

UDG Healthcare plc operates across three divisions: Ashfield Commercial & Medical Services, Sharp Packaging Services and Supply Chain Services.

Ashfield Commercial & Medical Services is a global leader in the provision of sales, marketing and healthcare communications services to pharmaceutical manufacturers with operations in major developed markets. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to healthcare companies in 19 countries.

Sharp Packaging Services is a leading international provider of pharmaceutical contract packaging and clinical trials materials services with facilities in the US, UK, the Netherlands and Belgium.

Supply Chain Services includes the United Drug Supply Chain Services and the Aquilant Specialist Healthcare Services businesses. The division provides logistics services to healthcare companies, pharmacies and hospitals in the UK and Ireland. United Drug Supply Chain Services is the largest pharmaceutical wholesaler and pre-wholesaler on the island of Ireland. Aquilant Specialist Healthcare Services is a leading provider of outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in Ireland and the UK.

On September 18 the Group announced the proposed sale of United Drug Supply Chain Businesses and MASTA (part of the Ashfield Division) to McKesson Corporation. The United Drug Supply Chain Businesses to be disposed of do not include the Aquilant Business. The disposal was approved by shareholders at an EGM on 13 October 2015. It is subject to competition authority clearance.

For more information please go to: www.udghealthcare.com